The Presidential Task Force on COVID-19, says Plateau State has now become the epicentre of COVID-19 infection. It noted that case spike has shifted from Lagos, Kano, Ogun and Oyo to Plateau State. The PTF Chairman and Secretary to the Government of the Federation, Boss Mustapha, disclosed this during the PTF media briefing in Abuja on Thursday. Recalling when the country recorded its index case, an Italian, six months ago, Mustapha said Nigeria has done remarkably well but could do exceedingly better. “The PTF would also like to draw our attention to a subtle change in the epicentre of the virus. “We all recall that Lagos, Kano and Ogun states were the initial epicentres and then to Oyo at a time, it is now Plateau State. “As mentioned by the Lagos State Commissioner
A new study conducted in the United Kingdom has revealed that COVID-19 worsened the condition of patients with eating disorders. The study conducted by researchers in the Department of Psychology, Northumbria University, Newcastle and published in the online edition of Journal of Eating Disorders, revealed that COVID-19 negatively affected nine out of 10 people with eating disorders According to the study, disruptions to daily life as a result of lockdown and social distancing may have a detrimental impact on an individual’s wellbeing, with almost nine out of ten (87 per cent) of participants reporting that their symptoms had worsened as a result of the pandemic while over 30 per cent of participants stated that their symptoms were much worse. The researchers collected data from 1
Recent reports indicate that the on-going Coronavirus disease (COVID-19) has led to scarcity and rise in prices of essential medicines, sanitisers, Personal Protective Equipment (PPEs) and medical products. Unconfirmed reports suggest that the situation has led to more people patronising counterfeit and fake or substandard medicines – both to prevent and treat COVID-19. The situation has raised lots of questions: What are the possible sources of fake and substandard drugs at times like this? What are the implications on efforts to contain COVID-19? What are the best ways to address the situation? A consultant clinical pharmacist, public health specialist/health educator and National Chairman, Association of Hospital and Administrative Pharmacists in Nigeria (AHAPN), Dr. Kingsley Ch
The Pharmaceutical Society of Nigeria has lamented that many pharmaceutical companies have not been able to access the Central Bank of Nigeria’s N100bn credit facility. According to the PSN, pharmaceutical firms have been facing all sorts of difficulties in their attempts to access the CBN’s intervention fund. It could be recalled that the CBN had announced on March 25, 2020, that it has earmarked N100bn credit support for the health sector to ameliorate the effect of COVID-19 pandemic. The official circular signed by CBN’s Director of Financial Policy and Regular Department, Kevin Amugo directed that all deposit banks accede to loan requests from indigenous pharmaceutical manufacturers and healthcare practitioners intending to ramp up their capacity. PSN President, Sam Ohuabun
Physicians under the aegis of the Association of General and Private Medical Practitioners of Nigeria have appealed to the Federal Government to rescue the health sector from total collapse. Speaking with journalists during a discussion on the implementation of the Federal Government’s proposed Emergency Medical System and Ambulance Services on Saturday, AGPMPN President, Dr. Ugwu Iyke Odo stated that only an intervention fund can save the health sector from dying. “We are requesting that the FG remember the health sector especially now that it has become very obvious that we are far from where we should be. “The health sector is sick and dying. We need to cure it. One way to do this is by bailout and intervention fund just as the FG has done to ensure that the banking and agricul
Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) Prof. Mojisola Adeyeye on Tuesday stated that pieces of evidence from reliable researches and reports showed that Chloroquine can kill COVID-19 virus at the early stage. She stated that Remdesivir, made by Gilead Sciences Inc, has also been shown to kill the virus at late stages. The NAFDAC boss, however, noted that the cost for treating people with chloroquine was way cheaper than with Remdesivir. Remdesivir cost $2,500 to treat an average patient and Chloroquine is $10. She also noted that countries in West Africa like Ghana, Togo, and Senegal have also embraced the clinical use of Chloroquine for treatment. Prof. Adeyeye spoke on Tuesday during a virtual news conference in Abu...
The World Health Organisation on Tuesday said it is working to ensure that when a proven safe and effective COVID-19 vaccine is available, it will be accessible to all countries. The WHO’s Director-General, Tedros Adhanom Ghebreyesus disclosed this during the live virtual session of the 70th WHO Regional Committee for Africa. Ghebreyesus said the organisation has been working round the clock since the earliest days of the COVID-19 pandemic, noting that African countries now have a preparedness and response plan in place. The WHO chief added that the African continent is facing a health crisis unlike any before. “Our continent is facing a health crisis unlike any we have faced before. “Yesterday, we crossed 1 million reported cases in the region, with more than 20,000 deaths.
The World Health Organisation has certified the African region polio-free. The independent Africa Regional Certification Commission, responsible for certifying the eradication of wild poliovirus in the WHO African Region, made its final decision about the region’s wild poliovirus – free status on Tuesday. Africa’s wild polio-free status was determined based on the field verification visits over the past year and on the critical analysis of the documentation of the polio surveillance, immunization and laboratory capacity presented by the governments of Cameroon, Central African Republic, Nigeria and South Sudan. In August 2019, the African Region became eligible to be certified free of wild poliovirus, after Nigeria, the last wild poliovirus endemic country, recorded no new cases t
Hong Kong scientists are reporting the case of a healthy man in his 30s who became re-infected with coronavirus four and a half months after his first bout. They say genome sequencing shows the two strains of the virus are "clearly different", making it the world's first proven case of reinfection. The World Health Organization warns it is important not to jump to conclusions based on the case of one patient. And experts say reinfections may be rare and not necessarily serious. There have been more than 23 million cases of coronavirus infection around the world. Those infected develop an immune response as their bodies fight off the virus which helps to protect them against it returning. The strongest immune response has been found in the most seriously ill patients. B...
The World Health Organisation says 172 countries are now engaging with the COVAX Global Vaccines Facility, which has the largest and most diverse COVID-19 vaccine portfolio in the world. The WHO’s Director-General Tedros Adhanom Ghebreyesus disclosed this at the media briefing on COVID-19 on Monday. He noted that nine vaccines are part of this dynamic portfolio; which is constantly being reviewed and optimised to ensure access to the best possible range of products. He said “I am pleased to announce that as of today 172 countries are now engaging with the COVAX Global Vaccines Facility, which has both the largest and most diverse COVID-19 vaccine portfolio in the world. “At present, there are nine vaccines that are part of this dynamic portfolio; which is constantly being revie
The World Health Organization (WHO) said children aged 12 and over should wear masks to help tackle the COVID-19 pandemic under the same conditions as adults, while children between six and 11 should wear them on a risk-based approach. Children aged 12 and over should particularly wear a mask when a one-metre distance from others cannot be guaranteed and there is widespread transmission in the area, the WHO and the United Nations Children’s Fund (UNICEF) said in a document on the WHO website dated Aug. 21. Whether children between six and 11 should wear masks depends on a number of factors, including the intensity of transmission in the area, the child’s ability to use the mask, access to masks and adequate adult supervision, the two organisations said. The pot
The World Health Organisation says there is no guarantee the discovery of a vaccine will end the COVID-19 pandemic currently ravaging the world. The Director-General of WHO, Dr. Tedros Adhanom Ghebreyesus disclosed this during the virtual media briefing on COVID-19 on Friday. He noted that everyone must learn to control and manage the virus using the tools that are presently available, adding that everyone must make the needed adjustments to stay safe and keep others safe. According to him, several countries around the world are now experiencing fresh outbreaks after a long period with little or no transmission. “These countries are a cautionary tale for those that are now seeing a downward trend in cases. Progress does not mean victory. “The fact remains that most people
The Director-General, Nigeria Centre for Disease Control, Dr. Chikwe Iheweazu, says Nigeria can avoid the second wave of COVID-19 infection if all citizens collectively work towards containing the spread of the viral pandemic. According to the NCDC DG, the second wave of COVID-19 infection is not inevitable; adding that averting it depends a lot on what is done by all Nigerians. Speaking in a live TV interview, the NCDC DG noted that the country can reduce the rate of infection “if we really focus on this thing for the next few months’ until there is a vaccine. Ihekweazu said “we are still very much in the middle of the first wave and that we will have a second wave is not inevitable. It depends a lot on what we do collectively as a country and that’s really is the most import
New research from a European group of smell disorder experts at the University of East Anglia, shows that, while COVID-19 patients can breathe freely, and do not tend to have a runny or blocked nose, and lose their sense of smell, they seem to lose their sweet and bitter tastes more. The study of how smell and taste loss associated with COVID-19 infection differs from people with other causes of upper respiratory tract infections, lend weight to the theory that COVID-19 infects the brain and central nervous system. The research team hope that their work could help develop smell and taste tests for fast COVID-19 screening – in primary care and emergency departments. According to the Lead researcher of the team, Prof Carl Philpott, from the University’s Norwich Medical School: “The l
Regeneron and Roche are teaming up on an investigational antibody cocktail against COVID-19, with the U.S. company to sell it in the United States and the Swiss drugmaker to sell it elsewhere, should the drug win approval. Regeneron has said it expects initial data from on-going trials of its COVID-19 antibody cocktail, called REGN-COV2, next month. The medicine, among several being developed by drugmakers seeking a treatment for the novel coronavirus, prevented and treated the disease in rhesus macaques and hamsters, Regeneron said this month. Together with Roche, Regeneron aims to increase the overall production capacity of REGN-COV2 by at least three and a half times in a bid to meet eventual U.S. and global need. Roche's move to join forces with Regeneron comes after...